As the 2025 legislative session progresses in North Carolina, there is a renewed focus on cannabis reform, particularly concerning medical marijuana legalization and the regulation of hemp-derived products.
Senate President Pro Tempore Phil Berger (R) has indicated a potential pathway for advancing cannabis legislation. Senate Minority Leader Sydney Batch (D) echoed this sentiment, identifying cannabis reform as a key non-partisan issue poised for movement in 2025. This bipartisan acknowledgment underscores the growing consensus within the legislature regarding the need for a regulated cannabis program. Overall, legislators have indicated the importance of establishing a comprehensive framework for both medical cannabis and hemp-derived cannabinoids.
The 2025 session presents a critical opportunity for lawmakers to reconcile previous legislative differences and establish a regulated cannabis program. The potential coupling of medical cannabis legalization with regulations on hemp-derived products reflects a comprehensive approach to cannabis policy, aiming to provide patients with access to medical marijuana while ensuring consumer safety in the growing hemp market.
As the session unfolds, stakeholders and citizens alike will be closely monitoring the legislature's actions on this issue, hopeful for a resolution that addresses both medical needs and hemp market regulation.